Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EMILY RACHEL MIHAILESCU

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1053970939
CMS profile
10808209
Location
MILFORD, CT

General Payments · PY2021–2024

$5,736.56

  • Reported across 337 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,068.90

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,068.90 33

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $237.66 11
Alkermes, Inc. $214.31 5
ABBVIE INC. $175.04 4
Otsuka America Pharmaceutical, Inc. $125.01 1
Neurocrine BioSciences, Inc. $121.33 4
Gilead Sciences, Inc. $95.54 3
Indivior Inc. $50.73 2
Vanda Pharmaceuticals Inc. $17.89 1
Merck Sharp & Dohme Corporation $15.87 1
Corium, Inc. $15.52 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $2,263.28 158
PY2022 $2,087.13 131
PY2023 $317.25 15
PY2024 $1,068.90 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $27.61 04/23/2024 Food and Beverage Undisputed 01/23/2026 1107659374 CMS
ABBVIE INC. $125.00 07/11/2024 Food and Beverage Undisputed 01/23/2026 1107659376 CMS
ABBVIE INC. $15.43 11/15/2024 Food and Beverage Undisputed 01/23/2026 1107659378 CMS
ABBVIE INC. $7.00 12/12/2024 Food and Beverage Undisputed 01/23/2026 1107659380 CMS
Alkermes, Inc. $22.98 05/09/2024 Food and Beverage Undisputed 01/23/2026 1120554777 CMS
Alkermes, Inc. $22.85 08/15/2024 Food and Beverage Undisputed 01/23/2026 1120554779 CMS
Alkermes, Inc. $21.24 09/17/2024 Food and Beverage Undisputed 01/23/2026 1120554781 CMS
Alkermes, Inc. $122.88 10/16/2024 Food and Beverage Undisputed 01/23/2026 1120554783 CMS
Alkermes, Inc. $24.36 11/13/2024 Food and Beverage Undisputed 01/23/2026 1120554785 CMS
Corium, LLC $15.52 10/24/2024 Food and Beverage Undisputed 01/23/2026 1100214199 CMS
Gilead Sciences, Inc. $32.50 03/14/2024 Food and Beverage Undisputed 01/23/2026 1133666226 CMS
Gilead Sciences, Inc. $32.69 04/11/2024 Food and Beverage Undisputed 01/23/2026 1133666228 CMS
Gilead Sciences, Inc. $30.35 07/18/2024 Food and Beverage Undisputed 01/23/2026 1133666230 CMS
Indivior Inc. $24.11 11/11/2024 Food and Beverage Undisputed 01/23/2026 1144563263 CMS
Indivior Inc. $26.62 12/30/2024 Food and Beverage Undisputed 01/23/2026 1144563265 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.16 05/16/2024 Food and Beverage Undisputed 01/23/2026 1143551551 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.55 06/04/2024 Food and Beverage Undisputed 01/23/2026 1143551556 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $26.75 06/17/2024 Food and Beverage Undisputed 01/23/2026 1143551559 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.25 06/25/2024 Food and Beverage Undisputed 01/23/2026 1143551563 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.68 07/11/2024 Food and Beverage Undisputed 01/23/2026 1143551567 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.30 08/19/2024 Food and Beverage Undisputed 01/23/2026 1143551572 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.12 09/13/2024 Food and Beverage Undisputed 01/23/2026 1143551576 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.13 09/16/2024 Food and Beverage Undisputed 01/23/2026 1143551580 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1.72 09/16/2024 Food and Beverage Undisputed 01/23/2026 1143551583 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $34.20 10/29/2024 Food and Beverage Undisputed 01/23/2026 1143551587 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.80 11/08/2024 Food and Beverage Undisputed 01/23/2026 1143551592 CMS
Merck Sharp & Dohme LLC $15.87 06/03/2024 Food and Beverage Undisputed 01/23/2026 1141643962 CMS
Neurocrine Biosciences, Inc. $35.38 08/01/2024 Food and Beverage Undisputed 01/23/2026 1150931735 CMS
Neurocrine Biosciences, Inc. $29.00 09/12/2024 Food and Beverage Undisputed 01/23/2026 1150942179 CMS
Neurocrine Biosciences, Inc. $32.24 11/04/2024 Food and Beverage Undisputed 01/23/2026 1150935534 CMS
Neurocrine Biosciences, Inc. $24.71 11/19/2024 Food and Beverage Undisputed 01/23/2026 1150956429 CMS
Otsuka America Pharmaceutical, Inc. $125.01 11/06/2024 Food and Beverage Undisputed 01/23/2026 1119138643 CMS
Vanda Pharmaceuticals Inc. $17.89 10/21/2024 Food and Beverage Undisputed 01/23/2026 1133958294 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.